Arcellx

Arcellx, Inc. is a clinical-stage biotechnology company that is pioneering the future of cell therapy. Their mission is to advance humanity by developing cell therapies that are safer, more effective, and more broadly accessible. They focus on developing novel immunotherapies for patients with cancer and other incurable diseases, such as multiple myeloma, acute myeloid leukemia, and myelodysplastic syndrome. Arcellx has established itself as a leader in the field through their innovative D-Domain technology, which is a synthetic binding scaffold that enhances the safety, efficacy, and accessibility of cell therapies.

Arcellx has two proprietary platforms based on the D-Domain technology, ddCAR and ARC-SparX. The ddCAR platform utilizes D-Domains in chimeric antigen receptors (CARs) to target specific antigens on diseased cells. The ARC-SparX platform is a dosable and controllable CAR-T therapy that combines ARC-T cells and specialized SparX proteins to bind to and kill targeted disease cells. Arcellx's lead product candidate, anito-cel, is a ddCAR targeting the BCMA antigen and is currently in a pivotal Phase 2 trial for patients with relapsed or refractory multiple myeloma. Arcellx is also developing its ARC-SparX platform through two Phase 1 programs.

Arcellx prioritizes work-life balance and offers employees a variety of benefits and perks to support this. They provide a company-wide 3-day weekend every month in addition to regular holidays, unlimited paid time off to recharge and live a balanced life, and six months of fully paid leave for birthing parents and two months of fully paid leave for other parents, as well as adoption assistance.

Arcellx offers a comprehensive suite of employee benefits aimed at fostering well-being and a sense of community. These include a unique 3-day weekend every month to promote mental wellness, 100% health insurance premium coverage for employees and their families, six months full-paid leave for birthing parents and two months for other parents, unlimited flexible time away, a 3% company contribution to retirement savings, and equity compensation.

Arcellx is a biotechnology company focused on engineering cell therapies that are safer, more effective, and more broadly accessible to treat patients with cancer and other incurable diseases. Their mission is to advance humanity through the development of these novel cell therapies, aiming to transform how patients are treated and ultimately achieve a cure.

Arcellx promotes a culture of authenticity, respect, continuous improvement, and challenging the status quo. They value a diverse workforce and encourage team members to bring their whole selves to work, recognizing the unique value each individual brings to the table. They emphasize collaboration, mutual respect, and a shared commitment to advancing humanity through innovative cell therapies. This is reflected in their core values of "Be Authentic," "Bring Your Unique Value," "Get Better Every Day," and "Challenge the Status Quo," fostering an environment where employees feel supported, empowered, and inspired to make a difference.

Arcellx values diversity, equity, and inclusion, recognizing that a team comprised of individuals with diverse backgrounds, perspectives, and experiences delivers superior results. The company actively cultivates an environment where everyone feels welcome, respected, and supported, fostering a sense of belonging and empowering employees to contribute their unique value. Arcellx believes that embracing diversity strengthens its team, enriches its culture, and ultimately contributes to its success in the fight against cancer.